AIHTA - Publications - Search - Nivolumab (Opdivo®) in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma

Rothschedl, E. and Grössmann, N. (2024): Nivolumab (Opdivo®) in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. Fact Sheet Nr. 174.

[thumbnail of Fact Sheet Nr.174.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
280kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WJ Urogenital system > WJ 400-600 Ureter. Bladder. Urethra
Language:English
Series Name:Fact Sheet Nr. 174
Deposited on:12 Jun 2024 16:55
Last Modified:12 Jun 2024 16:55

Repository Staff Only: item control page